Corindus Vascular Robotics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

25.10.19	Corindus Vascular Robotics, Inc. Stockholders Approve Acquisition by Siemens Healthineers (Businesswire)
18.09.19	Corindus to Showcase CorPath® GRX System at Transcatheter Cardiovascular Therapeutics 2019 Conference (Businesswire)
03.09.19	First-in-Human Telerobotic Coronary Intervention Procedures Published in The Lancet Journal, EClinicalMedicine (Businesswire)
08.08.19	Corindus Reports Second Quarter 2019 Results (Businesswire)
08.08.19	DERM On Watchlist, FDA Panel Nod For GILD, So Long, CVRS And AVDR (RTTNews)
08.08.19	Siemens Healthineers To Buy Corindus Vascular Robotics For About $1.1 Bln (RTTNews)
08.08.19	Corindus Vascular Robotics Announces Definitive Agreement to Be Acquired by Siemens Healthineers (Businesswire)
05.08.19	Corindus to Present at Canaccord Genuity 39th Annual Growth Conference on August 8, 2019 (Businesswire)
25.07.19	Corindus to Report Second Quarter 2019 Financial Results on August 8, 2019 (Businesswire)
18.07.19	Corindus Adds Two New CorPath GRX Installations to HCA Healthcare Facilities (Businesswire)
17.07.19	Corindus Announces Regulatory Approval of CorPath GRX for Neurovascular Intervention in Australia and New Zealand (Businesswire)
09.07.19	Corindus Announces First Commercial Installation of CorPath® GRX System in South America (Businesswire)
01.07.19	Corindus Joins Russell 3000® Index (Businesswire)
23.05.19	Corindus CorPath GRX System Successfully Used in Live Complex Robotic-Assisted Coronary Intervention at EuroPCR 2019 (Businesswire)
20.05.19	Corindus to Showcase CorPath® GRX Robotic System at EuroPCR 2019 (Businesswire)
17.05.19	Corindus to Present "Evolution of Robotics: Automation, Remote Applications, and Beyond” at SCAI 2019 Breakfast Symposium on May 21, 2019 (Businesswire)
07.05.19	Corindus Reports First Quarter 2019 Results (Businesswire)
07.05.19	Corindus Equips the World’s First Fully Robotic Catheterization Laboratory (Businesswire)
29.04.19	Corindus to Report First Quarter 2019 Financial Results on May 7, 2019 (Businesswire)
15.04.19	Corindus Announces First Robotic-Assisted Interventions in Japan for CorPath GRX Post-Market Study (Businesswire)
29.03.19	Corindus Vascular Robotics Files Required Registration Statement for Holders of Recently Completed $19.8 Million Private Placement (Businesswire)
12.03.19	Corindus Reports Fourth Quarter and Full Year 2018 Results (Businesswire)
12.03.19	Corindus Vascular Robotics Announces Additional Closing of Private Placement (Businesswire)
05.03.19	Corindus to Report Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019 (Businesswire)
05.03.19	Corindus to Present at 39th Annual Cowen Health Care Conference on March 13, 2019 (Businesswire)
26.02.19	Corindus Vascular Robotics Announces Closing of Private Placement for $15 Million (Businesswire)
14.02.19	Corindus Announces FDA Submission for Neurovascular Intervention Indication for CorPath® GRX Vascular Robotic System (Businesswire)
06.12.18	Corindus’ Technology Successfully Used in World’s First-in-Human Telerobotic Coronary Intervention (Businesswire)
07.11.18	Corindus to Present at Upcoming 2018 Healthcare Conferences (Businesswire)
06.11.18	Corindus Reports Third Quarter 2018 Results (Businesswire)
30.10.18	Corindus to Report Third Quarter Financial Results on November 6, 2018 (Businesswire)
01.10.18	Corindus Technology Successfully used in Multiple Live Complex Robotic-Assisted Coronary Interventions at Transcatheter Cardiovascular Therapeutics 2018 (Businesswire)
24.09.18	Corindus Announces First Live Transmission of Remote Robotic Demonstration Performed at Transcatheter Cardiovascular Therapeutics 2018 Conference (Businesswire)
17.09.18	Corindus to Present at Ladenburg Thalmann 2018 Healthcare Conference (Businesswire)
23.08.18	Corindus to Present at 13th Annual Wells Fargo Securities Healthcare Conference (Businesswire)
07.08.18	Corindus Reports Second Quarter 2018 Results (Businesswire)
06.08.18	Corindus to Showcase CorPath GRX® System for Peripheral Vascular Interventions at the 2018 Amputation Prevention Symposium (Businesswire)
03.08.18	Corindus to Report Second Quarter Financial Results on August 7, 2018 (Businesswire)
03.08.18	Corindus to Present at Canaccord Genuity 38th Annual Growth Conference (Businesswire)
19.07.18	Corindus Announces Significant Progress in the Development of Remote Vascular Robotic Technology with the CorPath GRX® System (Businesswire)
11.07.18	Corindus Names Aquilla S. Turk, D.O. as Chief Medical Officer, Neuroendovascular (Businesswire)
19.06.18	Corindus Promotes Doug Teany to Chief Operating Officer (Businesswire)
08.06.18	Corindus Announces Pharmaceutical and Medical Device Agency (PMDA) Approval of CorPath GRX System in Japan (Businesswire)
08.05.18	Corindus Reports First Quarter 2018 Results (Businesswire)
27.04.18	Corindus to Report First Quarter Financial Results on May 8, 2018 (Businesswire)
23.04.18	Corindus Presents "Optimizing Care with CorPath GRX: Hot Topics in Robotic Interventions" at SCAI 2018 Dinner Symposium on April 26 (Businesswire)
16.03.18	Corindus Announces $25 Million Private Placement of Series A Convertible Preferred Shares and Warrants (Businesswire)
14.03.18	Corindus Reports Fourth Quarter and Full Year 2017 Results (Businesswire)
13.03.18	Corindus to Report Fourth Quarter and Full Year 2017 Financial Results on March 14, 2018 (Businesswire)
13.03.18	James R. Tobin Joins Corindus Board of Directors (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Corindus Vascular Robotics

Aktien Top/Flop

Meistgelesene Nachrichten